Insider trading allegations at Gland Pharma
A company associated with the management is said to have divested a 4% stake when it likely had access to unpublished price-sensitive information.
3 November, 2022•6 min
0
3 November, 2022•6 min
0
Getting your Trinity Audio player ready...
Why read this story?
Editor's note: A little over a year ago, Gland Pharma was a star stock to own. Shares of the Hyderabad-based injectables maker, owned by Chinese conglomerate Fosun, hit a high of Rs 4,287 in August last year—up from Rs 1,500 in its November 2020 IPO—giving it a valuation of around Rs 70,000 crore. That put it on a par with Dr Reddy’s Laboratories, which had five times the revenue of Gland. The story stands in sharp contrast today. The stock has fallen 54% since January and its valuation is around Rs 31,000 crore. Foreign institutional investors have reduced their stake by half, a bunch of promoter entities have sold out, even as some domestic institutions have increased their holdings. While the company posted increased revenue and profits in the two latest fiscal years (2020-21 and 2021-22), a lot has soured in the last two quarters. When the company declared its earnings for the second quarter of the current fiscal year last week, the stock dropped 15% in a trading session. It was the biggest drop in a day since its listing. For …
More in Business
Business
BOB's Rs 10,000-crore green bond cracks open a new market for Indian banks
The state-owned lender’s successful issuance—and rare pricing advantage—signals India’s hesitant sustainable finance market may finally be maturing
You may also like
Chaos
Why UAE’s stability premium is under question
For years, the country has been insulated from West Asia’s conflicts. Six days into the Iran war, that status is under strain—and investors could be recalibrating.
Business
SEBI’s overdue expansion is underway, but top-level gaps persist
India’s market regulator is looking to ramp up hiring at the entry level. But what really needs attention is the constant uncertainty at the top and the lack of domain experts.
Internet
Can SEBI get a good social media team for investor education?
With social media becoming a crucial source of financial guidance, it doesn’t help that many first-time investors remain strikingly unaware of regulations meant to protect them against unregistered entities.
